Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study

Glioblastoma (GBM) is a hypervascular and aggressive primary malignant tumor of the central nervous system. Recent investigations showed that traditional therapies along with antiangiogenic therapies failed due to the development of post-therapy resistance and recurrence. Previous investigations sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Sehar, Borin, Thaiz F., Piranlioglu, Raziye, Ara, Roxan, Lebedyeva, Iryna, Angara, Kartik, Achyut, Bhagelu R., Arbab, Ali Syed, Rashid, Mohammad H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864405/
https://www.ncbi.nlm.nih.gov/pubmed/33544755
http://dx.doi.org/10.1371/journal.pone.0246646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864405/
https://www.ncbi.nlm.nih.gov/pubmed/33544755
http://dx.doi.org/10.1371/journal.pone.0246646

Ejemplares similares